4-(N-(3-(trifluoromethyl)phenyl)sulfamoyl)benzoic acid, 250mg

N-[(1R,2R)-2-Amino-1,2-diphenylethyl]-1,1,1-trifluoromethanesulfonamide, 97%, 1g

[2-(2-Hydroxy-ethoxy)-ethyl]-carbamic acid benzylester, 95+%, 1g

(R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one, 98%, 50mg

2,2-Dimethylpentanedinitrile, 95%, 5g

4-(chloromethyl)-2-cyclopropylthiazole hydrochloride, 95.0%, 250mg

1-Docosene, 99.0%, 100g

3-Hydroxy-[1,1'-biphenyl]-4,4'-dicarbonitrile, 95.0%, 1g

Methyl 4-(2-bromophenyl)-2,4-dioxobutanoate, 95.0%, 5g

D-(+)-Arabitol>98.0%(GC)25g

(2E)-1-(2,4-dimethoxyphenyl)-3-(4-ethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

(3-Fluoro-phenyl)-methanesulfonyl chloride, 95.0%, 25g

(S)-5-isopropyl-2-(perfluorophenyl)-2,5,6,8-tetrahydro-[1,2,4]triazolo[3,4-c][1,4]oxazin-4-iumtetrafluoroborate, 97%, 10g